收藏切换
Eliminating postoperative residual toxins in bladder cancer with insect drugs: a strategy grounded in the “latent pathogens in collaterals” theory
收藏切换
Can-lin WANG1, Qing WANG2, Bing LI1, Jin-ting LÜ1, Yi-wei ZHONG1, Jian-xin LU1, Ya-qiang ZHANG1, Shu-qi SONG1, *
Chinese Journal of New Drugs | 2026, 35(10) : 1017 - 1023
Less
收藏切换
Chinese Journal of New Drugs | 2026, 35(10): 1017-1023
Eliminating postoperative residual toxins in bladder cancer with insect drugs: a strategy grounded in the “latent pathogens in collaterals” theory
Full
Can-lin WANG1, Qing WANG2, Bing LI1, Jin-ting LÜ1, Yi-wei ZHONG1, Jian-xin LU1, Ya-qiang ZHANG1, Shu-qi SONG1, *
Affiliations
  • 1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
  • 2Beijing University of Chinese Medicine, Beijing 100029, China
Published: 2026-05-30 doi: 10.20251/j.cnki.1003-3734.2026.10.002
Outline
收藏切换

Based on the theory of "Pathogens Lurking in the Collaterals" proposed by Ye Tianshi in "Case Reports for Clinical Practice", the principle of "using insect-form medicines to attack and expel the latent pathogen" provides significant guidance for eliminating residual toxins after bladder cancer surgery. According to collateral disease theory, both surgical trauma and chronic illness leading to deficiency can result in pathogenic toxins invading collaterals with stasis and impairment. This pathological mechanism underlies post-operative recurrence in bladder cancer patients due to pathogens lurking within the collaterals. Based upon the "Pathogens Lurking in the Collaterals" theory and integrating modern medical research, this paper proposes that insect-form medicines can inhibit bladder tumor growth and improve the tumor microenvironment through multi-target actions. These include resolving phlegm and dissipating masses, breaking stasis and unblocking collaterals, searching out toxins and dredging collaterals, and warming the kidney to promote qi flow. Furthermore, we systematically elucidate the clinical deployment patterns of insect-based agents and summarize their characteristic therapeutic applications. It is anticipated that these insights will provide novel perspectives for Traditional Chinese Medicine (TCM) in the prophylaxis and management of post-resection bladder cancer recurrence.

latent pathogens in collaterals  /  insect drugs  /  tumor mircroenvironment  /  bladder cancer  /  postoperative recurrence
王灿霖, 王晴, 李冰, 吕晋廷, 钟毅薇, 卢建新, 张亚强, 宋竖旗. 基于“邪伏络脉”探讨运用虫类药清除膀胱癌术后余毒的策略. 中国新药杂志, 2026 , 35 (10) : 1017 -1023 . DOI: 10.20251/j.cnki.1003-3734.2026.10.002
Can-lin WANG, Qing WANG, Bing LI, Jin-ting LÜ, Yi-wei ZHONG, Jian-xin LU, Ya-qiang ZHANG, Shu-qi SONG. Eliminating postoperative residual toxins in bladder cancer with insect drugs: a strategy grounded in the “latent pathogens in collaterals” theory[J]. Chinese Journal of New Drugs, 2026 , 35 (10) : 1017 -1023 . DOI: 10.20251/j.cnki.1003-3734.2026.10.002
Year 2026 volume 35 Issue 10
58
11
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2026.10.002
  • Online Date:2026-10-26
  • Published:2026-05-30
Article Data
Affiliations
History
  • Accepted:2025-09-14
Funding
Affiliations
    1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    2Beijing University of Chinese Medicine, Beijing 100029, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.10.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT